IRTC iRhythm Technologies Inc

Price (delayed)

$138.75

Market cap

$4.05B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.58

Enterprise value

$4.08B

Sector: Healthcare
Industry: Medical Instruments & Supplies

Highlights

IRTC's equity has surged by 152% year-on-year and by 2.1% since the previous quarter
The EPS has increased by 27% YoY and by 18% from the previous quarter
The quick ratio has soared by 76% YoY but it has contracted by 13% from the previous quarter
The gross margin has contracted by 2.6% YoY

Key stats

What are the main financial stats of IRTC
Market
Shares outstanding
29.16M
Market cap
$4.05B
Enterprise value
$4.08B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
11.73
Price to sales (P/S)
14.52
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
15.39
Earnings
Revenue
$265.17M
EBIT
-$42.08M
EBITDA
-$29.15M
Free cash flow
-$27.31M
Per share
EPS
-$1.58
Free cash flow per share
-$0.98
Book value per share
$11.83
Revenue per share
$9.55
TBVPS
$18.41
Balance sheet
Total assets
$511.74M
Total liabilities
$170.13M
Debt
$122.47M
Equity
$341.61M
Working capital
$312.16M
Liquidity
Debt to equity
0.36
Current ratio
5.75
Quick ratio
5.56
Net debt/EBITDA
-1.16
Margins
EBITDA margin
-11%
Gross margin
73.5%
Net margin
-16.5%
Operating margin
-16.5%
Efficiency
Return on assets
-11.2%
Return on equity
-19.1%
Return on invested capital
-11%
Return on capital employed
-9.4%
Return on sales
-15.9%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

IRTC stock price

How has the iRhythm Technologies stock price performed over time
Intraday
-3.08%
1 week
-13.77%
1 month
-22.69%
1 year
36.83%
YTD
-41.51%
QTD
-41.51%

Financial performance

How have iRhythm Technologies's revenue and profit performed over time
Revenue
$265.17M
Gross profit
$194.89M
Operating income
-$43.67M
Net income
-$43.83M
Gross margin
73.5%
Net margin
-16.5%
IRTC's operating margin is up by 35% YoY and by 22% from the previous quarter
The net margin is up by 35% YoY and by 21% from the previous quarter
The revenue has grown by 24% YoY and by 8% from the previous quarter
The company's gross profit rose by 20% YoY and by 7% QoQ

Growth

What is iRhythm Technologies's growth rate over time

Valuation

What is iRhythm Technologies stock price valuation
P/E
N/A
P/B
11.73
P/S
14.52
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
15.39
The EPS has increased by 27% YoY and by 18% from the previous quarter
IRTC's equity has surged by 152% year-on-year and by 2.1% since the previous quarter
IRTC's P/B is 45% below its 5-year quarterly average of 21.2 and 44% below its last 4 quarters average of 20.9
The revenue has grown by 24% YoY and by 8% from the previous quarter
The P/S is 23% below the last 4 quarters average of 18.8 but 10% above the 5-year quarterly average of 13.2

Efficiency

How efficient is iRhythm Technologies business performance
iRhythm Technologies's ROE has soared by 67% YoY and by 34% from the previous quarter
The ROA has soared by 52% YoY and by 26% from the previous quarter
IRTC's return on invested capital is up by 42% year-on-year and by 21% since the previous quarter
The ROS has increased by 35% YoY and by 21% from the previous quarter

Dividends

What is IRTC's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for IRTC.

Financial health

How did iRhythm Technologies financials performed over time
The quick ratio has soared by 76% YoY but it has contracted by 13% from the previous quarter
The current ratio has surged by 73% year-on-year but it has declined by 12% since the previous quarter
The debt is 64% less than the equity
IRTC's equity has surged by 152% year-on-year and by 2.1% since the previous quarter
The debt to equity has plunged by 62% YoY and by 5% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.